Hansoh Pharmaceutical Group Company Limited reported a net issuance of 9.00 million ordinary shares in April 2026, lifting its total outstanding share count to 6.06 billion.

Authorised Capital • Authorised share capital closed the month unchanged at 20.00 billion ordinary shares with a par value of HKD 0.00001 each, equating to HKD 0.20 million.

Issued Shares • Opening balance (31 Mar 2026): 6.06 billion shares. • New shares issued: 9.00 million shares, allocated on 17 Apr 2026 under the Restricted Share Unit (RSU) scheme adopted on 27 May 2019 at an issue price of HKD 3.5788 per share. • Closing balance (30 Apr 2026): 6.06 billion shares. • The company held no treasury shares at month-end.

Convertible Bonds • Zero-coupon convertible bonds due 2033, issued on 3 Feb 2026, remained unchanged at HKD 4.68 billion. • Potential dilution: 81.55 million new shares may be issued upon full conversion at a price of HKD 57.39 per share. • No conversions occurred during the month.

Public Float • Management confirmed compliance with the minimum 16.21% public-float threshold stipulated at listing.

No activity was recorded for share options, warrants, Hong Kong Depositary Receipts or other equity instruments. The filing was submitted by Joint Company Secretary Ms. Zhong Shengli on 4 May 2026.